Brain Cancer

In honor of the second annual Glioblastoma Awareness Day in the United States, Erica Finamore shares her story of the journey and untimely passing of her husband Jon Marc. But how that passing has still given to the research of brain cancer.

The EndBrainCancer Initiative wants patient concerns reflected in national treatment guidelines.

From a skin cancer survivor raising money for the fight against the novel coronavirus to a Cleveland Browns fan who has survived a rare brain tumor helping to open the broadcast of Thursday’s NFL Draft, here’s what is making headlines in the cancer space this week.

Going in for an infusion amid the coronavirus pandemic with a possible "symptom" of COVID-19 and wondering what risks lie ahead.

At the best of times, cancer is a difficult burden to bear, but in the midst of a pandemic, it's especially worse. But patients with cancer know the way out is by going through.

One survivor offers her suggestions to handle chemo brain as she copes with her almost-10-year-old chemo brain.

With the start of a new decade, a brain cancer patient discovers what may be the most courageous way to move forward in his life.

From a weight loss drug’s possible cancer risk to a shocking cancer revelation in the death of ESPN reporter Edward Aschoff, here’s what is making headlines in the cancer space this week.

From a bill that would improve access to care for patients with stage 4 cancer to the death of Roxette lead singer Marie Fredrikksson, here’s what is making headlines in the cancer space this week.

Friends would often ask me why I was doing all this running and biking. I had no answer for them. Now, looking back, I know that God was preparing me for the biggest race of my life: my cancer journey!

While scientists have a limited understanding of how brain metastases genetically evolve from their primary tumor, research presented at the Society for Neuro-Oncology’s Annual Meeting may have identified a connection between genetic mutations and treatment options that could offer patients improved outcomes.

Researchers developed SurVaxM to help stimulate an immune response in patients with glioblastoma.

"I’m trying to turn my season of yes into a season of consideration. A season in which I weigh what I can do, with what I’d like to do, and with a radical honesty with my community around what that means and what a low-impact, beautiful, accepting, good life looks like. I hope that season lasts for a long time."

After receiving a diagnosis of medulloblastoma at age 11, one woman has lived decades with the disease as her uninvited companion. Now, she writes, speaks and advocates for others facing cancer.

Here is a list of the recent trial initiations that occurred within the cancer space in October.

“Lasting Love” shares a moving and constructive message that may help support youngsters as they navigate a deep loss.

From a chemotherapy drug shortage to Eddie Van Halen revealing a cancer diagnosis, here’s what is making headlines in the cancer space this week.

After receiving a stage 4 brain cancer diagnosis, a young mother traveled from Mexico to Chicago for treatment.

Here’s a look at what’s inside our 2019 Rare Cancers special issue.

At free NCI clinics, people with some of the rarest disease get tumor analysis, counseling and expert advice.

After two years, the Biden Cancer Initiative has shuttered as former Vice President Joe Biden’s presidential campaign begins in earnest.

Long-term survivors of pediatric neuroblastoma may be at an increased risk for neurocognitive impairment – in particular, due to age at diagnosis and the type of treatment received.

The FDA has approved Zirabev, a biosimilar to Avastin, for the treatment of five types of cancer: colorectal cancer; non-small cell lung cancer; glioblastoma; metastatic renal cell carcinoma; and persistent, recurrent or metastatic cervical cancer.

Don’t let a terminal diagnosis get you down to the point where you stop living your life. Have an adventure, buy the shoes and eat the cake.

This cancer living inside of me has been life altering. On the outside you may think that things are not so bad. What you are not seeing is that my cancer is incurable.

This essay was written by her colleagues, Jeanine Gordon and Jaclyn Andronico, Memorial Sloan Kettering Cancer Center, nominating Lisa Klempner, M.S.N., RN, OCN for CURE®’s 2019 Extraordinary Healer® Award.

From the 9/11 Victim Compensation Fund to the untimely passing of an inspirational Olympic runner, here’s what is making headlines in the cancer space this week.

Amy Setesak, B.S.N., RN, CMSRN from Memorial Sloan Kettering Cancer Center, New York, was nominated by her colleague, Aly Fox, B.S.N., RN, CMSRN, for CURE®’s Extraordinary Healer® Award.

Four out of 100. That is the survival rate for stage 4 glioblastoma: four percent.